Loading...
•
Sep 30, 2023
UFP Technologies Q3 2023 Earnings Report
UFP Technologies reported strong Q3 2023 results with increased adjusted net income and sales.
Key Takeaways
UFP Technologies announced a 13.8% increase in adjusted net income to $11.9 million for Q3 2023, compared to $10.4 million in Q3 2022. Sales for the quarter reached $100.8 million, up from $97.0 million in the same period last year. The company's growth initiatives, including expansion in low-cost country facilities, are progressing, with investments in the Dominican Republic, Costa Rica, and Mexico expected to drive future growth.
Adjusted net income increased by 13.8% to $11.9 million in Q3 2023.
Q3 sales reached $100.8 million, compared to $97.0 million in Q3 2022.
Organic revenue growth in Q3 was 5.6%, with Medical sales up 6.8%.
Investments in Dominican Republic, Costa Rica, and Mexico facilities are expected to drive growth.
Revenue by Segment
Forward Guidance
UFP Technologies anticipates that growth should accelerate as they enter next year and are excited about their growth potential in 2024, which should benefit from the significant investments.
Positive Outlook
- Growth should accelerate as they enter next year.
- Benefit from the significant investments.
- Continuing efforts to identify strategic acquisition candidates.
- Increased competitiveness against private equity buyers.
- Expansion plans in low-cost country facilities.
Challenges Ahead
- Customers delaying releases due to excess inventory.
- Covid-related caution.
- Start-up costs and related inefficiencies have reduced gross margins.
- High interest rates have slowed deal flow.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...